Koss MA - Search Results

1

Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.

Ballesteros MA, Hogan DL, Koss MA, Isenberg JI. Ballesteros MA, et al. Among authors: koss ma. Ann Intern Med. 1990 Mar 1;112(5):334-9. doi: 10.7326/0003-4819-112-5-334. Ann Intern Med. 1990. PMID: 2306061 Clinical Trial.

2

Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.

Hogan DL, McQuaid KR, Koss MA, Crombie DL, Hunter S, Metz C, Euler AR, Isenberg JI. Hogan DL, et al. Among authors: koss ma. Aliment Pharmacol Ther. 1993 Oct;7(5):537-41. doi: 10.1111/j.1365-2036.1993.tb00130.x. Aliment Pharmacol Ther. 1993. PMID: 8280822 Clinical Trial.

3

Anti-secretory effects and pharmacokinetics of low dose ranitidine.

Koss MA, Hogan DL, Lane J, Steinbach JH, Isenberg JI. Koss MA, et al. Aliment Pharmacol Ther. 1993 Aug;7(4):417-22. doi: 10.1111/j.1365-2036.1993.tb00115.x. Aliment Pharmacol Ther. 1993. PMID: 8218756 Clinical Trial.

4

Human duodenal mucosal bicarbonate secretion. Evidence suggesting active transport under basal and stimulated conditions.

Odes HS, Hogan DL, Ballesteros MA, Wolosin JD, Koss MA, Isenberg JI. Odes HS, et al. Among authors: koss ma. Gastroenterology. 1990 Apr;98(4):867-72. doi: 10.1016/0016-5085(90)90009-p. Gastroenterology. 1990. PMID: 2311874

5

Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.

Thomas FJ, Koss MA, Hogan DL, Isenberg JI. Thomas FJ, et al. Among authors: koss ma. Am J Med. 1986 Aug 18;81(2A):44-9. doi: 10.1016/s0002-9343(86)80010-9. Am J Med. 1986. PMID: 3092654 Clinical Trial.

6

Effect of basal gastric acid secretion on the pharmacodynamics of ranitidine.

Sanders SW, Ballersteros MA, Hogan DL, Koss MA, Isenberg JI. Sanders SW, et al. Among authors: koss ma. Chronobiol Int. 1991;8(3):186-93. doi: 10.3109/07420529109063925. Chronobiol Int. 1991. PMID: 1794156

7

Bicarbonate transport by rabbit duodenum in vitro: effect of vasoactive intestinal polypeptide, prostaglandin E2, and cyclic adenosine monophosphate.

Yao B, Hogan DL, Bukhave K, Koss MA, Isenberg JI. Yao B, et al. Among authors: koss ma. Gastroenterology. 1993 Mar;104(3):732-40. doi: 10.1016/0016-5085(93)91008-6. Gastroenterology. 1993. PMID: 8382644

8

Cigarette smoking inhibits acid-stimulated duodenal mucosal bicarbonate secretion.

Ainsworth MA, Hogan DL, Koss MA, Isenberg JI. Ainsworth MA, et al. Among authors: koss ma. Ann Intern Med. 1993 Nov 1;119(9):882-6. doi: 10.7326/0003-4819-119-9-199311010-00003. Ann Intern Med. 1993. PMID: 8214999

9

Indomethacin inhibits duodenal mucosal bicarbonate secretion and endogenous prostaglandin E2 output in human subjects.

Selling JA, Hogan DL, Aly A, Koss MA, Isenberg JI. Selling JA, et al. Among authors: koss ma. Ann Intern Med. 1987 Mar;106(3):368-71. doi: 10.7326/0003-4819-106-3-368. Ann Intern Med. 1987. PMID: 3468819 Clinical Trial.

10

The effect of vasoactive intestinal peptide, secretin, and glucagon on human duodenal bicarbonate secretion.

Wolosin JD, Thomas FJ, Hogan DL, Koss MA, O'Dorisio TM, Isenberg JI. Wolosin JD, et al. Among authors: koss ma. Scand J Gastroenterol. 1989 Mar;24(2):151-7. doi: 10.3109/00365528909093030. Scand J Gastroenterol. 1989. PMID: 2928730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results